Basal insulin for the management of diabetic ketoacidosis

Keyphrases

• Diabetic Ketoacidosis 100%
• Basal Insulin 100%
• Insulin Infusion 60%
• Intravenous Insulin 40%
• Rebound Hyperglycemia 40%
• Regular Insulin 40%
• Adverse Effects 20%
• Maintenance Therapy 20%
• Hyperglycemia 20%
• Continuous Subcutaneous Insulin Infusion 20%
• Prospective Randomized Trial 20%
• Adult Patients 20%
• Pediatric Patients 20%
• Management Approach 20%
• ICU Stay 20%
• Total Dose 20%
• New Therapeutic Approaches 20%
• Small Sample Size 20%
• High Insulin 20%
• Cost Reduction 20%
• Acidosis 20%
• Concomitant Administration 20%
• Pharmacokinetic Properties 20%
• Insulin Requirement 20%
• Hypokalemia 20%
• Acute Management 20%
• Intravenous Insulin Infusion 20%
• Long-acting Insulin Analog 20%
• Ketoacidosis 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Hyperglycemia 100%
• Diabetic Ketoacidosis 100%
• Insulin Analog 66%
• Pig Insulin 66%
• Adverse Event 33%
• Pharmacokinetics 33%
• Hypokalemia 33%
• Long Acting Insulin 33%
• Ketoacidosis 33%